Literature DB >> 6197519

In situ methotrexate polyglutamate formation in rat tissues.

G R Krakower, B A Kamen.   

Abstract

Rats given a single i.p. injection of 10 mg/kg of methotrexate rapidly accumulate drug in several tissues, including liver, kidneys, testes, brain and red cells. Using a tissue extraction procedure which minimizes the breakdown of methotrexate polyglutamate derivatives and molecular sieve high-performance liquid chromatography, we examined the formation of methotrexate polyglutamates in these tissues throughout a period of 1 week after a single dose of drug. Higher polyglutamates (n greater than 3) were found in the brain, liver, kidneys and testes as early as 3 hr. The percentage of methotrexate polyglutamates increases slowly in the liver, kidney, testis and brain during the course of the week, concomitant with a decline of unconjugated tissue methotrexate and a low plasma concentration of drug. This is in contrast to the blood cells, which have little polyglutamate formation and a rapid half-life for methotrexate. The consistently high levels of methotrexate polyglutamate levels found in the liver, kidneys, testes and brain are in agreement with data showing little or no disappearance of methotrexate from these tissues for up to 26 days.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197519

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Methotrexate (MTX) concentration in tumors following low-dose MTX.

Authors:  N J Winick; B A Kamen; A Streckfuss; J Craig; F McGuirt; R L Capizzi; F Sklar; D Coln
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Trimetrexate: a new antifol entering clinical trials.

Authors:  P J O'Dwyer; D D Shoemaker; J Plowman; J Cradock; A Grillo-Lopez; B Leyland-Jones
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

3.  The activities of antioxidant enzymes and the level of malondialdehyde in cerebellum of rats subjected to methotrexate: protective effect of caffeic acid phenethyl ester.

Authors:  Ertugrul Uzar; Hasan Rifat Koyuncuoglu; Efkan Uz; H Ramazan Yilmaz; Suleyman Kutluhan; Serkan Kilbas; Fatih Gultekin
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

4.  Methotrexate kinetics in myeloid bone marrow cells and peripheral neutrophils.

Authors:  H Schrøder
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Methotrexate pharmacokinetics in age-fractionated erythrocytes.

Authors:  H Schrøder
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  Dihydrofolate reductase-activity in brain tissue. Effect of X-irradiation.

Authors:  R Ludwig; E Frei; B Kimmig; W E Brandeis
Journal:  Blut       Date:  1987-12

7.  In vivo decline of methotrexate and methotrexate polyglutamates in age-fractionated erythrocytes.

Authors:  H Schrøder; K Fogh; T Herlin
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.